Table 7.
Association between elevated NGAL and the prevalence of high HbF in patients with T2DM.
| Elevated NGAL (>180.5 ng/mL) | Prevalence of high HbF | |
|---|---|---|
| Odds ratio (95% CI) | P value | |
| Unadjusted | 2.53 (1.21–5.47) | <0.001 |
| Adjusted for | ||
| Age and sex | 1.98 (1.16–4.03) | <0.001 |
| Age, sex, and BMI | 1.72 (1.12–3.64) | <0.001 |
| Age, sex, BMI, and SBP | 1.45 (1.09–3.07) | <0.001 |
| Age, sex, BMI, SBP, eGFR, and smoking history | 1.27 (1.03–2.51) | <0.001 |
NGAL: neutrophil gelatinase-associated lipocalin; BMI: body mass index; SBP: systolic blood pressure; eGFR: estimated glomerular filtration rate; HbF: fetal hemoglobin; CI: confidence interval.